keyword
https://read.qxmd.com/read/38569861/-veno-venous-extracorporeal-membrane-oxygenation-for-capillary-leak-syndrome-during-induction-chemotherapy-in-acute-myeloid-leukemia
#21
JOURNAL ARTICLE
Tadashi Okamura, Shogo Murata, Kyohei Miyamoto, Misato Tane, Yuka Okabe, Satomi Takeda, Shotaro Tabata, Hideki Kosako, Yoshikazu Hori, Yusuke Yamashita, Toshiki Mushino, Hiroki Hosoi, Takashi Sonoki
A 44-year-old woman was diagnosed with acute myeloid leukemia (RUNX1::RUNX1T1 translocation) and received induction chemotherapy with idarubicin hydrochloride and cytosine arabinoside. The pneumonia that had been present since admission worsened, and a drug-induced skin rash appeared. On day 17, she presented with respiratory failure and shock, complicated by hemoconcentration and hypoalbuminemia. This was considered capillary leak syndrome due to pneumonia and drug allergy, so she was started on pulse steroid therapy and IVIG, and was intubated on the same day...
2024: [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology
https://read.qxmd.com/read/38569435/infectious-respiratory-pathogens-among-patients-with-acute-exacerbation-of-idiopathic-pulmonary-fibrosis-during-the-coronavirus-disease-2019-pandemic-in-japan
#22
JOURNAL ARTICLE
Kentaro Akata, Kei Yamasaki, Takako Kawaguchi, Yosuke Chiba, Konomi Sennari, Saki Shigemi, Kazuki Nemoto, Midori Funada, Katsunori Suzuki, Kazuhiro Yatera
BACKGROUND: Few studies have investigated the prevalence of pathogens in patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), specifically, the interactions between respiratory pathogens and AE-IPF during the coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVES: We aimed to analyze pathogens in patients with AE-IPF between September 2020 and December 2022. METHODS: This retrospective observational study was conducted at our hospital between September 2020 and December 2022...
April 2, 2024: Heart & Lung: the Journal of Critical Care
https://read.qxmd.com/read/38567195/prevalence-of-chronic-pulmonary-aspergillosis-in-two-2-tuberculosis-treatment-clinics-in-lagos-nigeria-a-prospective-longitudinal-study
#23
JOURNAL ARTICLE
Adeyinka A Davies, Abiola O Adekoya, Oluwaseyi J Balogun, Iriagbonse I Osaigbovo, Augustina Nwosu, Titilola Gbaja-Biamila, Olubunmi Osinupebi, Jean-Pierre Gangneux, Rita O Oladele
BACKGROUND: Chronic pulmonary aspergillosis (CPA) is an underrecognized but common complication of pulmonary tuberculosis. In Nigeria, a tuberculosis-endemic country, there is currently no provision to monitor the development of CPA in patients treated for tuberculosis. This study determined the prevalence and incidence of CPA in Lagos, Nigeria. METHODS: A prospective longitudinal study of patients with previously managed tuberculosis was conducted between June 2021 and May 2022...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38564365/high-dose-isoniazid-lacks-early-bactericidal-activity-against-isoniazid-resistant-tuberculosis-mediated-by-katg-mutations-a-randomized-phase-2-clinical-trial
#24
JOURNAL ARTICLE
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
RATIONALE: Observational studies suggest that high-dose isoniazid may be efficacious in treating multidrug-resistant tuberculosis (MDR-TB). However, its activity against Mycobacterium tuberculosis ( M.tb ) with katG mutations (which typically confer high-level resistance) is not established. OBJECTIVE: To characterize early bactericidal activity (EBA) of high-dose isoniazid in patients with tuberculosis caused by katG -mutated M.tb . METHODS: A5312 was a Phase 2A randomized, open-label trial...
April 2, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38561815/a-pragmatic-randomized-controlled-trial-to-evaluate-the-efficacy-and-safety-of-an-oral-short-course-regimen-including-bedaquiline-for-the-treatment-of-patients-with-multidrug-resistant-tuberculosis-in-china-study-protocol-for-prospect
#25
JOURNAL ARTICLE
Jingtao Gao, Mengqiu Gao, Jian Du, Yu Pang, Gary Mao, Nacer Lounis, Nyasha Bakare, Yanxin Jiang, Ying Zhan, Yuhong Liu, Liang Li
INTRODUCTION: The lack of safe, effective, and simple short-course regimens (SCRs) for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment has significantly impeded TB control efforts in China. METHODS: This phase 4, randomized, open-label, controlled, non-inferiority trial aims to assess the efficacy and safety of a 9-month all-oral SCR containing bedaquiline (BDQ) versus an all-oral SCR without BDQ for adult MDR-TB patients (18-65 years) in China...
April 1, 2024: Trials
https://read.qxmd.com/read/38561652/a-hypervirulent-acinetobacter-baumannii-strain-has-robust-anti-phagocytosis-ability
#26
JOURNAL ARTICLE
Yan Li, Mohan Jv, Yuan Zhuang, Xu Zhao, Xiaoxiong Hu
BACKGROUND: Acinetobacter baumannii (A. baumannii) is associated with both hospital-acquired infections (HAP) and community-acquired pneumonia (CAP). In this study, we present a novel CAP-associated A. baumannii (CAP-AB) strain causing severe pneumonia in an afore healthy male patient without underlying conditions. Subsequently, we investigated the pathogenicity and immunogenicity of this CAP-AB strain using a mice pneumonia model. RESULTS: A 58-year-old male patient with no underlying conditions experienced worsening symptoms of a productive cough, sputum, and fever that developed acutely, in just 24 h...
April 1, 2024: BMC Microbiology
https://read.qxmd.com/read/38560028/acquired-rifamycin-resistance-among-patients-with-tuberculosis-and-hiv-in-new-york-city-2001-2023
#27
JOURNAL ARTICLE
Felicia Dworkin, Alice V Easton, Byron Alex, Diana Nilsen
INTRODUCTION: Acquired rifamycin resistance (ARR) in tuberculosis (TB) has been associated with HIV infection and can necessitate complicated TB treatment regimens, particularly in people living with HIV (PLWH). This work examines clinical characteristics and treatment outcomes of PLWH who developed ARR from 2001 to 2023 in New York City (NYC) to inform best practices for treating these patients. METHODS: PLWH who developed ARR 2001-2023 were identified from the NYC TB registry...
May 2024: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/38557639/safety-and-immunogenicity-of-the-h56-ic31-tuberculosis-vaccine-candidate-in-adults-successfully-treated-for-drug-susceptible-pulmonary-tb-a-phase-1-randomized-trial
#28
JOURNAL ARTICLE
Dereck Tait, Andreas Diacon, Álvaro H Borges, Elana van Brakel, David Hokey, Kathryn T Rutkowski, Devin J Hunt, Marisa Russell, Peter L Andersen, Ingrid Kromann, Morten Ruhwald, Gavin Churchyard, Rodney Dawson
BACKGROUND: H56:IC31 is a candidate vaccine against tuberculosis (TB) with the potential to reduce TB recurrence rate. It is thus important for future clinical trials to demonstrate safety and immunogenicity of H56:IC31 in individuals treated for TB. METHODS: 22 adults confirmed to be Mtb negative (by 2 GeneXpert tests or 2 sputum cultures) after four-five months of TB treatment, and not more than 28 days after completion of TB treatment, were randomized to receive two doses of H56:IC31 (5 mg H56:500 nmol IC31; N=16) or placebo (N=6) 56 days apart...
April 1, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38552876/m1-uk-streptococcus-pyogenes-causing-community-acquired-pneumonia-pleural-empyema-and-streptococcal-toxic-shock-syndrome
#29
JOURNAL ARTICLE
Angeliki Mavroidi, Anna Katsiaflaka, Efthymia Petinaki, Elisavet Froukala, Dimitrios Papadopoulos, Georgia Vrioni, Athanasios Tsakris
OBJECTIVES: Streptococcus pyogenes causes superficial infections, but can also cause deep-seated infections and toxin-mediated diseases. In the present study, phylogenetic and in silico prediction analyses were performed on an antimicrobial-resistant M1UK S. pyogenes strain causing severe clinical manifestations during the current surge of invasive group A Streptococcus (iGAS) disease. PATIENT AND METHODS: A 40-year-old patient was admitted to the hospital with fever, chest pain, and fatigue...
March 27, 2024: Journal of Global Antimicrobial Resistance
https://read.qxmd.com/read/38551904/towards-personalised-anti-microbial-and-immune-approaches-to-infections-in-acute-care-can-real-time-genomic-informed-diagnosis-of-pathogens-and-immune-focused-therapies-improve-outcomes-for-patients-an-observational-experimental-study-protocol
#30
JOURNAL ARTICLE
Samuel Quarton, Kirsty McGee, Nicola Cumley, Mahboobeh Behruznia, Charlotte Jeff, Kylie Belchamber, Michael Cox, David Thickett, Aaron Scott, Dhruv Parekh, Alan McNally, Elizabeth Sapey
INTRODUCTION: Infection causes a vast burden of disease, with significant mortality, morbidity and costs to health-care systems. However, identifying the pathogen causative infection can be challenging, resulting in high use of broad-spectrum antibiotics, much of which may be inappropriate. Novel metagenomic methods have potential to rapidly identify pathogens, however their clinical utility for many infections is currently unclear. Outcome from infection is also impacted by the effectiveness of immune responses, which can be impaired by age, co-morbidity and the infection itself...
2024: PloS One
https://read.qxmd.com/read/38538244/-a-case-of-silicosis-complicated-with-non-tuberculous-mycobacterium-pulmonary-disease
#31
JOURNAL ARTICLE
X L Hu, S Q Wang
Non-tuberculosis mycobacterium (NTM) refers to a general term for a large group of mycobacteria, excluding the mycobacterium tuberculosis and mycobacterium leprae, which is an opportunistic pathogen. NTM pulmonary disease and pulmonary tuberculosis have very similar clinical and imaging manifestations. Ordinary sputum tests can not distinguish between mycobacterium tuberculosis and NTM accurately, and it needs to be differentiated through detection methods such as mycobacterium culture medium, high-performance liquid chromatography, and molecular biology...
March 20, 2024: Chinese Journal of Industrial Hygiene and Occupational Diseases
https://read.qxmd.com/read/38536821/the-use-of-kudoh-method-for-culture-of-mycobacterium-tuberculosis-and-mycobacterium-africanum-in-the-gambia
#32
JOURNAL ARTICLE
Tijan Jobarteh, Jacob Otu, Ensa Gitteh, Francis S Mendy, Tutty Isatou Faal-Jawara, Boatema Ofori-Anyinam, Binta Sarr, Abi Janet Riley, Abigail Ayorinde, Bouke C de Jong, Beate Kampmann, Ousman Secka, Florian Gehre
BACKGROUND: Mycobacterium tuberculosis culturing remains the gold standard for laboratory diagnosis of tuberculosis. Tuberculosis remains a great public health problem in developing countries like The Gambia, as most of the methods currently used for bacterial isolation are either time-consuming or costly. OBJECTIVE: To evaluate the Kudoh swab method in a West African setting in Gambia, with a particular focus on the method's performance when culturing Mycobacterium africanum West Africa 2 (MAF2) isolates...
2024: PloS One
https://read.qxmd.com/read/38533387/talaromycosis-from-wuhan-two-case-report-and-literature-review
#33
REVIEW
Zhiyuan Yao, Zhou Pan, Guang Li, Zhaomin Liao, Zhen Yu, Liying Zhan, Wenfang Xia
BACKGROUND: Talaromycosis is a serious opportunistic infectious disease caused by Talaromyces marneffei , which mostly occurs in immunocompromised patients. The disease is mainly prevalent in tropical countries and regions of Southeast Asia and South Asia, but non-endemic areas also have patients with Talaromycosis. The disease has no characteristic clinical manifestations and is difficult to diagnose. Delayed diagnosis often leads to death. CASE PRESENTATION: Both patients had cellular immunodeficiency...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38532759/closure-of-tb-pulmonary-cavern-using-endobronchial-valve-placement
#34
Teona Mskhaladze, David Tchkonia, Kakha Vacharadze, Nana Kiria, Mikolay Chkonia
INTRODUCTION: Enhancing the efficacy of treatment for Multi-Drug Resistant (MDR) and Extensively Drug Resistant (XDR) Tuberculosis has prompted exploration into adjunctive therapies, such as Endobronchial Valve Placement (EVP) in addition to pharmacological interventions. MATERIALS AND METHODS: EVP was performed utilizing a combination of rigid and flexible bronchoscopes to address airway hemorrhage and facilitate closure of TB cavities. The procedure involved the deployment of large valves (12 mm and 17 mm), necessitating the utilization of a rigid bronchoscope...
March 2024: Oxford Medical Case Reports
https://read.qxmd.com/read/38532357/profile-of-non-tuberculous-mycobacteria-amongst-tuberculosis-presumptive-people-in-cameroon
#35
JOURNAL ARTICLE
Valerie Flore Donkeng Donfack, Thierry Anicet Zemo Fokou, Lazare Eric Noche Wadje, Yves Le Grand Napa Tchuedji, Yvonne Josiane Djieugoue, Sorelle Nguimfack Teagho, Brenda Shile Takong, Yannick Patrick Assolo, Suzanne Magloire Ongboulal, Yannick Willy Kamdem Simo, Stanley Nkemnji Awungafac, Sara Eyangoh
BACKGROUND: Cameroon is a tuberculosis (TB) burden country with a 12% positivity among TB presumptive cases. Of the presumptive cases with a negative TB test, some are infected with Non-tuberculous Mycobacteria (NTM). However, the diagnosis of NTM infections remains difficult due to the lack of tools in many laboratories, particularly in resource limited laboratories and remote setting. The present study was undertaken to determine NTM profile and associated comorbidities among TB presumptive people...
March 26, 2024: BMC Microbiology
https://read.qxmd.com/read/38531107/tuberculosis-in-united-states-bound-follow-to-join-asylees-2014-2019
#36
JOURNAL ARTICLE
Yecai Liu, Drew L Posey, Michelle S Weinberg, Christina R Phares
Persons may seek asylum in the United States or at a U.S. port of entry. Principal asylees are those who are granted asylum status. Their spouse and unmarried children under 21 years of age may be granted asylum if accompanying, or following to join, the principal asylees. U.S.-bound follow-to-join asylees must undergo an overseas medical examination that includes tuberculosis (TB) screening. Culture-based overseas TB screening in U.S.-bound follow-to-join asylees has not been evaluated. We evaluated data from overseas TB screening in 19,088 arrivals of follow-to-join asylees during 2014-2019 and assessed data from their postarrival evaluation, which is recommended for those at risk for TB...
March 26, 2024: American Journal of Tropical Medicine and Hygiene
https://read.qxmd.com/read/38527849/adjunctive-pascolizumab-in-rifampicin-susceptible-pulmonary-tuberculosis-proof-of-concept-partially-randomised-double-blind-placebo-controlled-dose-escalation-trial
#37
JOURNAL ARTICLE
Nicholas I Paton, Meera Gurumurthy, Qingshu Lu, Francesca Leek, Philip Kwan, Hiromi W L Koh, James Molton, Lalaine Mortera, Sullian Naval, Zamzurina Abu Bakar, Yong-Kek Pang, Lionel Lum, Tow Keang Lim, Gail B Cross, Ganesh Lekurwale, Hyungwon Choi, Veonice Au, John Connolly, Martin Hibberd, Justin A Green
BACKGROUND: Interleukin-4 (IL-4), increased in tuberculosis infection, may impair bacterial killing. Blocking IL-4 confers benefit in animal models. We evaluated safety and efficacy of pascolizumab (humanised anti-IL-4 monoclonal antibody) as adjunctive tuberculosis treatment. METHODS: Participants with rifampicin-susceptible pulmonary tuberculosis received a single intravenous infusion of pascolizumab or placebo; and standard 6-month tuberculosis treatment. Pascolizumab dose increased in successive cohorts: [1] non-randomised 0...
March 25, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38524398/high-blood-eosinophil-count-at-stable-state-is-not-associated-with-airway-microbiota-distinct-profile-in-copd
#38
JOURNAL ARTICLE
Jeanne-Marie Perotin, Anaëlle Muggeo, Quentin Lecomte-Thenot, Audrey Brisebarre, Sandra Dury, Claire Launois, Julien Ancel, Valérian Dormoy, Thomas Guillard, Gaëtan Deslee
PURPOSE: The heterogeneity of clinical features in COPD at stable state has been associated with airway microbiota. Blood eosinophil count (BEC) represents a biomarker for a pejorative evolution of COPD, including exacerbations and accelerated FEV1 decline. We aimed to analyse the associations between BEC and airway microbiota in COPD at stable state. PATIENTS AND METHODS: Adult COPD patients at stable state (RINNOPARI cohort) were included and characterised for clinical, functional, biological and morphological features...
2024: International Journal of Chronic Obstructive Pulmonary Disease
https://read.qxmd.com/read/38524070/mycobacterium-gordonae-infection-in-a-patient-with-non-small-cell-lung-cancer
#39
Alissa I Elanjian, Jason P Law, Borys Hrinczenko
Mycobacterium gordonae (MG) is one of the least pathogenic nontuberculous mycobacteria (NTM). We report an unusual case of MG infection in a patient with newly diagnosed lung cancer. A 61-year-old woman presented with shortness of breath and weight loss. Six months prior to admission, she was diagnosed with MG infection based on positive sputum cultures and bronchioalveolar lavage. Despite anti-mycobacterial therapy, her symptoms worsened and she lost approximately 100 pounds. A transbronchial biopsy obtained one week prior to admission revealed adenocarcinoma of the lung...
February 2024: Curēus
https://read.qxmd.com/read/38518684/non-tuberculous-mycobacterial-isolates-from-panama-a-retrospective-5-year-analysis-2017-2021
#40
JOURNAL ARTICLE
Prudencio González, Juan Domínguez, Pedro Del Cid, Samantha Rosas, Ariel Magallón-Tejada
BACKGROUND: The genus Mycobacterium includes well-known bacteria such as M. tuberculosis causing tuberculosis and M. leprae causing leprosy. Additionally, various species collectively termed non-tuberculous mycobacteria (NTM) can cause infections in humans and animals, affecting individuals across all age groups and health conditions. However, information on NTM infection prevalence in Panama is limited. METHODS: This study conducted a retrospective analysis of clinical records from 2017 to 2021, specifically focusing on patients with NTM isolates...
March 5, 2024: Journal of Infection and Public Health
keyword
keyword
103458
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.